Alcresta's Series C Round

Alcresta raised a round of funding on June 14, 2016.

Alcresta Therapeutics is dedicated to developing and commercializing novel enzyme-based products designed to treat gastrointestinal disorders and rare diseases. The company uses its technology platfor…

Articles about Alcresta's Series C Round: